Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1927 1
1950 1
1951 1
1952 2
1953 4
1954 6
1955 7
1957 2
1958 5
1959 2
1960 7
1961 10
1962 9
1963 10
1964 12
1965 12
1966 25
1967 28
1968 13
1969 17
1970 23
1971 18
1972 19
1973 15
1974 22
1975 28
1976 18
1977 18
1978 31
1979 32
1980 29
1981 52
1982 51
1983 59
1984 60
1985 59
1986 87
1987 112
1988 108
1989 104
1990 121
1991 128
1992 146
1993 121
1994 137
1995 146
1996 164
1997 144
1998 151
1999 127
2000 159
2001 144
2002 134
2003 143
2004 177
2005 154
2006 152
2007 165
2008 163
2009 174
2010 190
2011 215
2012 253
2013 249
2014 262
2015 249
2016 209
2017 232
2018 229
2019 200
2020 201
2021 249
2022 210
2023 209
2024 120

Text availability

Article attribute

Article type

Publication date

Search Results

6,823 results

Results by year

Filters applied: . Clear all
Page 1
Home-based cardiac rehabilitation using information and communication technology for heart failure patients with frailty.
Nagatomi Y, Ide T, Higuchi T, Nezu T, Fujino T, Tohyama T, Nagata T, Higo T, Hashimoto T, Matsushima S, Shinohara K, Yokoyama T, Eguchi A, Ogusu A, Ikeda M, Ishikawa Y, Yamashita F, Kinugawa S, Tsutsui H. Nagatomi Y, et al. Among authors: hashimoto t. ESC Heart Fail. 2022 Aug;9(4):2407-2418. doi: 10.1002/ehf2.13934. Epub 2022 May 9. ESC Heart Fail. 2022. PMID: 35534907 Free PMC article. Clinical Trial.
Effects of resistance training intensity on muscle quantity/quality in middle-aged and older people: a randomized controlled trial.
Otsuka Y, Yamada Y, Maeda A, Izumo T, Rogi T, Shibata H, Fukuda M, Arimitsu T, Miyamoto N, Hashimoto T. Otsuka Y, et al. Among authors: hashimoto t. J Cachexia Sarcopenia Muscle. 2022 Apr;13(2):894-908. doi: 10.1002/jcsm.12941. Epub 2022 Feb 20. J Cachexia Sarcopenia Muscle. 2022. PMID: 35187867 Free PMC article. Clinical Trial.
Comprehensive Genomic Profiling of Neuroendocrine Carcinomas of the Gastrointestinal System.
Yachida S, Totoki Y, Noë M, Nakatani Y, Horie M, Kawasaki K, Nakamura H, Saito-Adachi M, Suzuki M, Takai E, Hama N, Higuchi R, Hirono S, Shiba S, Kato M, Furukawa E, Arai Y, Rokutan H, Hashimoto T, Mitsunaga S, Kanda M, Tanaka H, Takata S, Shimomura A, Oshima M, Hackeng WM, Okumura T, Okano K, Yamamoto M, Yamaue H, Morizane C, Arihiro K, Furukawa T, Sato T, Kiyono T, Brosens LAA, Wood LD, Hruban RH, Shibata T. Yachida S, et al. Among authors: hashimoto t. Cancer Discov. 2022 Mar 1;12(3):692-711. doi: 10.1158/2159-8290.CD-21-0669. Cancer Discov. 2022. PMID: 34880079 Free PMC article.
Real-world survival outcome comparing abiraterone acetate plus prednisone and enzalutamide for nonmetastatic castration-resistant prostate cancer.
Tsujino T, Tokushige S, Komura K, Fukuokaya W, Adachi T, Hirasawa Y, Hashimoto T, Yoshizawa A, Saruta M, Ohno T, Nakamori K, Maenosono R, Nishimura K, Yamazaki S, Uchimoto T, Yanagisawa T, Mori K, Urabe F, Tsuzuki S, Iwatani K, Yamamoto S, Takahara K, Inamoto T, Kimura T, Ohno Y, Shiroki R, Azuma H. Tsujino T, et al. Among authors: hashimoto t. Cancer Med. 2023 Oct;12(19):19414-19422. doi: 10.1002/cam4.6536. Epub 2023 Sep 14. Cancer Med. 2023. PMID: 37706578 Free PMC article.
Editorial: Case reports in dermatology.
Recke A, Hashimoto T. Recke A, et al. Among authors: hashimoto t. Front Med (Lausanne). 2023 Aug 23;10:1269802. doi: 10.3389/fmed.2023.1269802. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37680618 Free PMC article. No abstract available.
Editorial: Autoimmune blistering diseases, volume II.
Li X, Di Zenzo G, Schmidt E, Joly P, Hashimoto T. Li X, et al. Among authors: hashimoto t. Front Immunol. 2023 Mar 16;14:1175962. doi: 10.3389/fimmu.2023.1175962. eCollection 2023. Front Immunol. 2023. PMID: 37006261 Free PMC article. No abstract available.
Effectiveness of cefmetazole versus meropenem for invasive urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli.
Hayakawa K, Matsumura Y, Uemura K, Tsuzuki S, Sakurai A, Tanizaki R, Shinohara K, Hashimoto T, Hase R, Matono T, Kato H, Mawatari M, Hara H, Hamada Y, Saito S, Ohmagari N, Doi Y. Hayakawa K, et al. Among authors: hashimoto t. Antimicrob Agents Chemother. 2023 Oct 18;67(10):e0051023. doi: 10.1128/aac.00510-23. Epub 2023 Sep 13. Antimicrob Agents Chemother. 2023. PMID: 37702483 Free PMC article.
S2k guidelines on the management of paraneoplastic pemphigus/paraneoplastic autoimmune multiorgan syndrome initiated by the European Academy of Dermatology and Venereology (EADV).
Antiga E, Bech R, Maglie R, Genovese G, Borradori L, Bockle B, Caproni M, Caux F, Chandran NS, Corrà A, D'Amore F, Daneshpazhooh M, De D, Didona D, Dmochowski M, Drenovska K, Ehrchen J, Feliciani C, Goebeler M, Groves R, Günther C, Handa S, Hofmann SC, Horvath B, Ioannidis D, Jedlickova H, Kowalewski C, Kridin K, Joly P, Lim YL, Marinovic B, Maverakis E, Meijer J, Patsatsi A, Pincelli C, Prost C, Setterfield J, Sprecher E, Skiljevic D, Tasanen K, Uzun S, Van Beek N, Vassileva S, Vorobyev A, Vujic I, Wang G, Wang M, Wozniak K, Yayli S, Zambruno G, Hashimoto T, Schmidt E, Mascarò JM Jr, Marzano AV. Antiga E, et al. Among authors: hashimoto t. J Eur Acad Dermatol Venereol. 2023 Jun;37(6):1118-1134. doi: 10.1111/jdv.18931. Epub 2023 Mar 25. J Eur Acad Dermatol Venereol. 2023. PMID: 36965110 Free PMC article.
6,823 results